NEW YORK, March 22 – Nycomed Amersham is continuing with its plans to launch an initial public offering of shares in its subsidiary Amersham Pharmacia Biotech on the Nasdaq this spring, despite the downturn in the economy and a warning from competitor Applied Biosystems, the company said Thursday.

“As far as the IPO goes, we continue to work through the normal process with the SEC in filing our registration statement,” Tracy Cheung, vice president of investor relations at AP Biotech, told GenomeWeb.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.